Back
Lycopodium Ltd. Vs. Insmed, Inc. Industry Stock Comparison
Sell
27
LYOPF
Lycopodium Ltd.
Last Price:
$7.20
Seasonality Move:
-8.47%
Sell
46
INSM
Insmed, Inc.
Last Price:
$174.52
Seasonality Move:
7.61%
Sell
27
Lycopodium Ltd. (LYOPF)
is a Sell
Is Lycopodium Ltd. a Buy, Sell or Hold?
-
The current Lycopodium Ltd. [LYOPF] share price is $7.20. The Score for LYOPF is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
LYOPF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Insmed, Inc. (INSM)
is a Sell
Is Insmed, Inc. a Buy, Sell or Hold?
-
The current Insmed, Inc. [INSM] share price is $174.84. The Score for INSM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
INSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LYOPF Stock Price Chart
What is Lycopodium Ltd.'s stock price today?
-
The Lycopodium Ltd. share price today is $7.20The current trend is relatively stagnant and LYOPF is experiencing slight buying pressure.
INSM Stock Price Chart
What is Insmed, Inc.'s stock price today?
-
The Insmed, Inc. share price today is $174.84Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight buying pressure.
LYOPF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 42.29 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.2 - 7.2) | Sell |
| Bollinger Bands (100): | (6.8 - 7.88) | Sell |
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.64 | Sell |
| Relative Strength Index (14 RSI): | 37.6 | Sell |
| Chaikin Money Flow: | 7900670 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (188.78 - 208.54) | Sell |
| Bollinger Bands (100): | (131.89 - 191.39) | Buy |
LYOPF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.2 | Sell |
| 20-day SMA: | 7.2 | Sell |
| 50-day SMA: | 7.43 | Sell |
| 200-day SMA: | 7.13 | Buy |
| 8-day EMA: | 7.2 | Sell |
| 20-day EMA: | 7.22 | Sell |
| 50-day EMA: | 7.3 | Sell |
| 200-day EMA: | 7.26 | Sell |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 189.94 | Sell |
| 20-day SMA: | 198.55 | Sell |
| 50-day SMA: | 186.85 | Sell |
| 200-day SMA: | 121.67 | Buy |
| 8-day EMA: | 187.6 | Sell |
| 20-day EMA: | 192.95 | Sell |
| 50-day EMA: | 184.53 | Sell |
| 200-day EMA: | 136 | Buy |
Lycopodium Ltd. Earnings Growth & LYOPF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Insmed, Inc. Earnings Growth & INSM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.77 per share, and an increase next year of $2.60 per share.
Lycopodium Ltd. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Insmed, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||